Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement

Journal of Rheumatology

Volumn 23, Issue 11, 1996, Pages 1921-1926

  Grau, Josep M ^a,b   Miró, Oscar ^a   Pedrol, Enric ^a   Casademont, Jordi ^a   Masanés, Ferran ^a   Herrero, Carme ^a   Haussman, Gisela ^a   Urbano Márquez, Alvaro ^a  

^a Department of Medicine ^*  (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Dermtomyositis; Idiopathic inflammatory myopathies; Interstitial lung disease

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; MALE; PRIORITY JOURNAL;

AGED; COHORT STUDIES; DERMATOMYOSITIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MUSCLE WEAKNESS; RESPIRATORY FUNCTION TESTS;

EID: 0029974015     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Hunninghake GW, Fauci AS: Pulmonary involvement in the collagen vascular disease (state of the art). Am Rev Respir Dis 1979;119:471-503.
2. Perlman SG, Barth WF: Polymyositis, breast carcinoma, and interstitial lung disease. J Rheumatol 1980,-7:348-52.
3. Songcharoen S, Raju SF, Pennebaker JB: Interstitial lung disease in polymyositis and dermatomyositis. J Rheumatol 1980;7:353-60.
4. Mills ES, Matthews WH: Interstitial lung disease in dermatomyositis. JAMA 1956;160:1467-70.
5. Dickey BF, Myers AR: Pulmonary disease in polymyositis/ dermatomyositis. Semin Arthritis Rheum 1984;14:60-76.
6. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV: Interstitial lung disease in polymyositis and dermatomyositis. Am Rev Respir Dis 1990;141:727-33.
7. Laroche M, Didier A, Cantagrel A, et al: Pneumopathie interstitielle lymphoïde précédant une polymyosite. Presse Med 1992;21:39-40.
8. Al-Janadi M, Smith CD, Karsh J: Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. J Rheumatol 1989;16:1592-6.
9. DePaso WJ, Winterbauer RH: Interstitial lung disease. Disease-a-month 1991;37:67-74, 99-100.
10. Berstein RM, Morgan SH, Chapman J, et al: Anti-Jo-1 antibody: A marker for myositis with interstitial lung disease. BMJ 1984;289:152-5.
11. Cervera R, Ramírez G, Fernández-Solá J, et al: Antibodies to endothelial cells in dermatomyositis: Association with interstitial lung disease. BMJ 1991;302:880-l.
12. Arsura EL, Greenberg AS: Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. Semin Arthritis Rheum 1988;18:29-37.
13. Crystal RG, Gadek JE, Ferrans VJ, Fulmer JD, Line BR, Hunninghake GW: Interstitial lung disease: Current concepts of pathogenesis, staging and therapy. Am J Med 1981;70:542-68.
14. Bohan A, Peter JB: Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7; 403-7.
15. Dalakas MC: Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med 1991;325:1487-98.
16. Tanimoto K, Nakano K, Kano S, etal: Classification criteria for polymyositis and dermatomyositis. J Rheumatol 1995;22:668-74.
17. Casademont J, Grau JM, Masanés F, Herrero C, Urbano-Márquez A: Analysis of the outcome of idiopathic inflammatory myopathies with particular emphasis on muscle capillary damage. Scand J Rheumatol 1993;22:292-8.
18. Medical Research Council: Aids to the examination of the peripheral nervous system. London: Her Majesty's Stationery Office, 1981: 1.
19. Estruch R, Grau JM, Fernández-Solá J, Casademont J, Monforte R, Urbano-Márquez A: Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy. Hum Pathol 1992;23:888-95.
20. Grau JM, Masanés F, Pedrol E, Casademont J, Fernández-Solá J, Urbano-Márquez A: Human immunodeficiency virus type 1 infection and myopathy: Clinical relevance of zidovudine therapy. Am Neural 1993;34:206-11.
21. Takizawa H, Shiga J, Moroi Y, Miyachi S, Nishiwaki M, Miyamoto T: Interstitial lung disease in dermatomyositis: Clinicopathological study. J Rheumatol 1987;14:102-7.
22. Gruhn WB, Díaz-Buxo JA: Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis. J Rheumatol 1987;14:1045-7.
23. O'Donnell K, Keogh B, Cantin A, Crystal RG: Pharmacological suppression of the neutrophil component of the alveolitis in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1987;136:288-92.
24. Johnson MA, Kwan S, Snell NJC, Nunn AJ, Darbyshire JH, Turner-Warwick M: Randomised controlled trial comprising prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 1989;44:280-8.
25. Urbano-Márquez A, Casademont J, Grau JM: Polymyositis/ dermatomyositis: The current position. Ann Rheum Dis 1991;50:191-5.
26. Grau JM, Herrero C, Casademont J, Fernández-Solá J, Urbano-Márquez A: Cyclosporine A as first choice for dermatomyositis. J Rheumatol 1994;21:381-2.
27. Urbano-Márquez A, Grau JM, Casademont J, Pedro-Botet JC, Serra A, Estruch R: Miopatia inflamatoria idiopática. Análisis de una serie de 30 casos. Med Clin (Bac) 1986;86:353-6.
28. Flammang d'Ortho MP, Cadranel J, Milleron B, et al: Atteintes pulmonaires interstitielles des polymyosites (PM) et dermatopolymyosites (DP). Rev Pneumol Clin 1991;47:29-36.
29. Schwarz MI, Matthay RA, Sahn SA, Stanford RE, Marmorstein BL, Scheinhorn DJ: Interstitial lung disease in polymyositis and dermatomyositis: Analysis of six cases and review of the literature. Medicine 1976;55:89-104.
30. Lakhanpal S, Lie JT, Conn DL, Martin WJ II: Pulmonary disease in polymyositis/dermatomyositis: A clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 1987;46:23-9.
31. Salmeron G, Greenberg SD, Lidsky MD: Polymyositis and diffuse interstitial lung disease: A review of the pulmonary histopathologic findings. Arch Intern Med 1981;141:1005-10.
32. Karpati G, Carpenter S: Idiopathic inflammatory myopathies. Curr Opin Neural Neurosurg 1988;l:806-14.
33. Yoshida S, Azizki M, Mimori T, Yamagata H, Inada S, Homma M: The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983;26:604-11.
34. Hochberg MC, Feldman D, Stevens MB, Arnett FC, Reichlin M: Antibody to Jo-1 in polymyositis/dermatomyositis: Association with interstitial pulmonary disease. J Rheumatal 1984;11:663-5.
35. Frazier AR, Miller RD: Interstitial pneumonitis in association with polymyositis and dermatomyositis. Chest 1974;65:403-1.
36. Harlam PL, Turton CWG, Lukoszek A, et al: Bronchoalveolar lavage fluid cell counts in cryptogenetic fibrosing alveolitis and their relation to therapy. Thorax 1980;35:328-39.
37. Turner-Warwick M, Haslam PL: The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenetic fibrosing alveolitis. Am Rev Respir Dis 1987;135:288-92.
38. Duncan PE, Griffin JP, Carcia A, et al: Fibrosing alveolitis in polymyositis. Am J Med 1974;47:621-6.
39. Maccioni FJ, Colebatch HJH: Management of fibrosing alveolitis with polymyositis dermatomyositis. Aust NZ J Med 1990;20:806-10.